Overview
Background
Dr Shakti Shrestha is Deputy Director of Research and Lecturer in Pharmacy Practice and Medicines Management at the School of Pharmacy and Pharmaceutical Sciences, The University of Queensland (UQ). His research program focuses on optimising medication use in older people and those with life‑limiting illness, with particular interests in deprescribing, medication safety, dementia and palliative care, quality use of medicines, and the implementation of evidence into practice.
Shakti conceived and co‑led the development of De‑TOPPLE, a deprescribing decision‑support framework designed to improve medication optimisation for older adults with limited life expectancy. He also served as a Research Fellow and Queensland site coordinator for the MRFF‑funded EMBRACE trial, evaluating strategies to enhance the implementation of evidence‑based psychotropic prescribing recommendations in Australian residential aged care. His broader research spans medicines optimisation, medication‑related quality of life, pharmacy practice, health services research, and implementation science, forming a coherent program aimed at reducing medication‑related harm and improving care outcomes for older populations, particularly those with palliative care needs.
He has published widely across ageing, medication safety, deprescribing and pharmacy practice, and received the 2025 Best Publication by an Early Career Researcher Award from the UQ School of Pharmacy and Pharmaceutical Sciences. He supervises PhD, postgraduate and undergraduate research projects in medicines optimisation, polypharmacy, deprescribing and medication use in older populations, integrating his research expertise into teaching and research training.
Shakti’s academic and research work is informed by extensive experience across pharmacy practice, clinical research, residential aged care and higher education in Australia, the United Kingdom and Nepal. He was awarded the 2018 Australian Research Training Scholarship for his PhD in Clinical Pharmacy and Pharmacy Practice at UQ and the 2022 Career Development Scholarship, through which he gained further clinical trail experience across Queensland Hospital and Health Services. He holds a Master of Science in Clinical Pharmacology with Distinction from the University of Aberdeen (UK), and Bachelor of Pharmaceutical Sciences with Distinction from Pokhara University (Nepal). During his Master's training in the UK, he gained research experience working with SITS-ISTR (Safe Implementation of Thrombolysis in Stroke-International Stroke Thrombolysis Registry) data within NHS Grampian.
Availability
- Dr Shakti Shrestha is:
- Available for supervision
Fields of research
Qualifications
- Bachelor (Honours) of Pharmaceutical Sciences, Pokhara University
- Masters (Coursework) of Clinical Pharmacology and Therapeutics, University of Aberdeen
- Doctor of Philosophy of Clinical Pharmacy and Pharmacy Practice, The University of Queensland
Research interests
-
Quality Use of Medicines
-
Medication optimisation / Deprescribing
-
Older adults
-
Palliative care
-
Dementia
Research impacts
Shakti’s research on deprescribing and medication optimisation has informed clinical guidance, professional education, research tools and implementation approaches for older people with life-limiting illness.
His evidence syntheses on deprescribing have been used beyond academic publication. They have informed a Choosing Wisely Italy recommendation on lipid-lowering therapy in people with limited life expectancy, contributed to the US Agency for Healthcare Research and Quality’s Making Healthcare Safer IV review, and been incorporated into CareSearch evidence collections supporting palliative-care practice. His work has also been selected by the Drug and Therapeutics Bulletin (BMJ) to inform practical evidence summaries for healthcare professionals.
Shakti conceived and co-led the development of De-TOPPLE, a person-centred deprescribing framework for older people with limited life expectancy. The framework has been incorporated into professional education, including the Pharmaceutical Society of Australia’s continuing pharmacy education and hospital-pharmacy education in Spain. He also developed the HATD tool, a validated measure of healthcare professionals’ attitudes towards deprescribing. The tool has been requested for translation and use by researchers internationally and is being used in subsequent intervention research.
Through the MRFF-funded EMBRACE trial, Shakti led implementation research examining how evidence-based recommendations for psychotropic medicine use can be translated into Australian residential aged care. His work with residents, family members and multidisciplinary health professionals identified practical strategies to address barriers to guideline implementation and quality improvement. This research has also been featured in Advanced Pharmacy Australia’s MedsScan, extending its reach to pharmacy professionals and aged-care practice.
Works
Search Professor Shakti Shrestha’s works on UQ eSpace
2015
Journal Article
Face-to-face Training as an Effective Approach for Teaching Rotahaler Technique in Newly Diagnosed Patients of Asthma and COPD
Poudel, R. S., Shrestha, S., Piryani, R. M., Prajapati, A. and Khatiwada, D. (2015). Face-to-face Training as an Effective Approach for Teaching Rotahaler Technique in Newly Diagnosed Patients of Asthma and COPD. Journal of the Nepal Medical Association, 53 (198), 148-150.
2015
Journal Article
Efficacy of combined antithrombotic, statins and anti-hypertensive agents in acute ischemic stroke
Poudel, Ramesh Sharma, Thapa, Lekhjung, Shrestha, Shakti, Khatiwada, Dipendra, Upadhyay, Nijan, Bhandari, Tirtha Raj and Shrestha, Asis (2015). Efficacy of combined antithrombotic, statins and anti-hypertensive agents in acute ischemic stroke. Journal of the Nepal Medical Association, 53 (197), 5-11. doi: 10.31729/jnma.2696
2014
Journal Article
Intravenous Thrombolysis and Risk Factors for Ischemic Stroke
Shrestha, Shakti, Poudel, Ramesh S.harma, Thapa, Lekh J.ung and Khatiwada, Dipendra (2014). Intravenous Thrombolysis and Risk Factors for Ischemic Stroke. JNMA: Journal of the Nepal Medical Association, 52 (193), 745-750. doi: 10.31729/jnma.2615
2014
Journal Article
Status of vitamin D and its association with stroke risk factors in patients with acute ischemic stroke in a tertiary care hospital
Thapa, Lekhjung, Shrestha, Asis, Pradhan, Manohar, Bhandari, Tirtha Raj, Shrestha, Shakti, Poudel, Ramesh Sharma, Pokhrel, Baburam and Poudel, Raju (2014). Status of vitamin D and its association with stroke risk factors in patients with acute ischemic stroke in a tertiary care hospital. Journal of the Nepal Medical Association, 52 (195), 935-939. doi: 10.31729/jnma.2719
Supervision
Availability
- Dr Shakti Shrestha is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Optimising Medication Use in Older Adults with Chronic Kidney Disease
Principal Advisor
Other advisors: Associate Professor Esther Lau, Dr Wubshet Tesfaye
-
Doctor Philosophy
Optimizing Clinical Pharmacology Outcomes: Integrating Smart Decision Support Systems to Manage Drug-Drug Interactions in Polypharmacy
Principal Advisor
Other advisors: Dr Wubshet Tesfaye
-
Doctor Philosophy
Exploring medication optimization among older people in low and middle-income countries: the case of Nepal.
Principal Advisor
Other advisors: Professor Lisa Nissen, Associate Professor Esther Lau
-
Doctor Philosophy
Enhancing adherence in people at high risk of kidney disease: Leveraging an artificial intelligence(AI)-supported technology
Associate Advisor
Other advisors: Associate Professor Adam La Caze, Dr Wubshet Tesfaye
-
Doctor Philosophy
Enhancing adherence in people at high risk of chronic kidney disease: Integrating AI technology with a pharmacist-led adherence-intensive review
Associate Advisor
Other advisors: Associate Professor Adam La Caze, Dr Meng-Wong Taing, Dr Jared Miles, Dr Wubshet Tesfaye
Media
Enquiries
For media enquiries about Dr Shakti Shrestha's areas of expertise, story ideas and help finding experts, contact our Media team: